Results 161 to 170 of about 2,710 (195)
Diabetes, Metabolic Syndrome and Obesity: Targets and TherapyManqiao Wang,* Rong Luan,* Boshi Liu, Yi Gong, Jinzhi Zhao, Xiteng Chen, Qianhui Yang, Jingjie Liu, Juping Liu, Yan Shao, Xiaorong Li Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center ...
Yan Shao, Juping Liu, Rong Luan
exaly +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
MIGRATION OF OZURDEX IMPLANT INTO THE ANTERIOR CHAMBER
RETINAL Cases & Brief Reports, 2012The purpose of this study was to report a novel complication of Ozurdex implantation in which the implant migrates into the anterior chamber and to describe the subsequent clinical course.After identification of the implant in the inferior anterior chamber, clinical photographs were obtained.
James A, Eadie +2 more
openaire +2 more sources
Dexamethasone Intravitreal Implant (Ozurdex)
Canadian Journal of Health Technologies, 2023CADTH recommends that Ozurdex not be reimbursed by public drug plans for the treatment of adult patients with diabetic macular edema (DME) who are pseudophakic and have had an inadequate response to prior anti–vascular endothelial growth factor (VEGF) therapy. Evidence from 1 clinical trial and 2 observational studies was insufficient to demonstrate
openaire +1 more source
PERSISTENT REMNANTS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX)
Retina, 2020Purpose: To describe persistent remnants of dexamethasone intravitreal implant (DEX implant) and evaluate the risk factors for remnant persistence in patients who received a DEX implant. Methods: This retrospective observational study involved a retrospective chart review of 133 ...
Jee Taek, Kim +2 more
openaire +2 more sources
Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex)
BMJ Case Reports, 2020A 59-year-old man with diabetic macular oedema was treated with a dexamethasone intravitreal implant (Ozurdex) to his right eye. Immediately after injection, the implant was noted to have extruded into the perilimbal subconjunctival space. The remnants of the implant were expeditiously removed the following day to avoid corneal decompensation and ...
Jessica Ong +3 more
openaire +2 more sources
OFFICE MANAGEMENT OF OZURDEX IMPLANT DISLOCATION INTO THE ANTERIOR CHAMBER
RETINAL Cases & Brief Reports, 2023Purpose: To describe a novel office procedure that permits the repositioning of an Ozurdex implant from the anterior chamber back into the vitreous cavity. Methods: Description of an office technique for Ozurdex repositioning using a 30-gauge needle.
Abhimanyu S, Ahuja +2 more
openaire +2 more sources
A New Suggested Strategy for Safe Injection of Ozurdex
Ophthalmic Surgery, Lasers and Imaging Retina, 2019BACKGROUND AND OBJECTIVES: Ozurdex intravitreal injection is performed via a patented injection device. However, there is a common misconception among ophthalmologists regarding the relation between the speed of applicator button depression and the speed of pellet injection.
Chelsey J, Krambeer +6 more
openaire +2 more sources
Pharmacokinetic model for drug delivery by Ozurdex
Drug Delivery and Translational ResearchSustained release of drugs by devices such as dexamethasone implant placed in vitreous humor can reduce the frequency of intravitreal injections. The duration over which the device provides therapeutic drug exposure is a critical parameter and so models for predicting ocular pharmacokinetics after placing the device in vitreous humor are valuable. This
Kumara Bommanahalli Nagaraju +3 more
openaire +2 more sources
Ozurdex bei Irvine-Gass-Syndrom
201428. Kongress der Deutschsprachigen Gesellschaft für Intraokularlinsen-Implantation, Interventionelle und Refraktive Chirurgie (DGII)
Krause, D, Krause, S, Schilling, H
openaire +2 more sources
Re: Split Ozurdex implant: a caution
Canadian Journal of Ophthalmology, 2013Rupak, Roy, Sandhya, Hegde
openaire +4 more sources